The association between intake of methylxanthines and risk of breast cancer was examined in this population-based casecontrol study conducted in Adelaide, South Australia. The study included 451 cases, and one control was matched to each case for age (to the nearest year). Overall, and within the po
Methylxanthines and breast cancer
โ Scribed by Catherine Schairer; Louise A. Brinton; Robert N. Hoover
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 503 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
We investigated the relationship between methylxanthine consumption and breast cancer using data from a case-control study which included 1,510 cases and 1,882 controls identified through a nation-wide breast cancer screening program. There was no evidence of a positive association between methylxanthine consumption and risk of breast cancer. In fact, there was some suggestion of a negative association, particularly in women diagnosed after age 50. In addition, there was no evidence of increased risk with past or recent methylxanthine consumption, or with the consumption of caffeine or specific beverages, most notably brewed or instant caffeinated coffee and tea.
๐ SIMILAR VOLUMES
Although diet and its constituents have been studied extensively as risk factors for colon cancer, much less is known about how specific types of fluid influence colon cancer risk. In this study, we explored associations between colon cancer and total fluids, water and methylxanthine-containing beve
Earlier detection of breast cancer through periodic screening is the only currently available intervention likely to reduce breast cancer-related mortality in the near term; prevention would be preferable. The alteration of proliferative changes and the assessment of intermediate endpoints may estab
Brachytherapy has been an important component of radiation therapy for breast cancer. It played a historical role in the development of breast-conserving techniques for early-stage breast cancer. The primary use for brachytherapy in this setting has been to deliver a localized boost dose of radiatio